Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 13  •  12:35PM ET
59.34
Dollar change
+0.66
Percentage change
1.13
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y9.00% Total Holdings66 Perf Week0.74%
SponsorJPMorgan Chase ETF Type Tagsequity Return% 3Y- AUM8.79M Perf Month-0.21%
Fund Family Bond Type Tagshealthcare Return% 5Y- NAV/sh Perf Quarter3.50%
Index- Average Maturity Tagsbiotechnology Return% 10Y 52W High59.69 -0.59% Perf Half Y18.40%
Index Weighting Commodity Type Tagspharmaceutical Return% SI 52W Low47.67 24.48% Perf YTD2.57%
Active/Passive Quant Type Tags- Flows% 1M0.00% Volatility0.12% 0.23% Perf Year9.14%
Dividend TTM0.51 (0.86%) ESG Type Tags- Flows% 3M0.00% ATR (14)0.40 Perf 3Y-
Dividend Ex-DateDec 16, 2025 Dividend Type Sector/Theme Flows% YTD0.00% RSI (14)56.54 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta0.49 Perf 10Y-
Expense0.65% Growth/Value SMA200.86% Flows% 3Y Rel Volume0.28 Prev Close58.68
Inverse/Leveraged Market Cap SMA501.54% Flows% 5Y Avg Volume0.97K Price59.34
IPONov 02, 2023 Option/ShortNo / Yes SMA20010.42% Trades Volume181 Change1.13%
Jpmorgan Healthcare Leaders ETF seeks to provide long-term capital appreciation. The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.